Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

3D-QSAR Studies of Tetraoxanes Derivatives as Antimalarial Agents Using CoMFA and CoMSIA Approaches

  • Liang, Taigang (School of Pharmaceutical Science, Shanxi Medical University) ;
  • Ren, Luhui (School of Pharmaceutical Science, Shanxi Medical University) ;
  • Li, Qingshan (School of Pharmaceutical Science, Shanxi Medical University)
  • Received : 2013.01.28
  • Accepted : 2013.03.25
  • Published : 2013.06.20
Download PDF
⟨ Previous Next ⟩

Abstract

Tetraoxanes (1,2,4,5-tetraoxanes) have been reported to exhibit potent antimalarial activity. In the present study, the three dimensional-quantitative structure activity relationship (3D-QSAR) studies were performed on a series of tetraoxanes derivatives using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques. The best predictive CoMFA model with atom fit alignment resulted in cross-validated coefficient ($q^2$) value of 0.719, non-cross-validated coefficient ($r^2$) value of 0.855 with standard error of estimate (SEE) 0.335. Similarly, the best predictive CoMSIA model was derived with $q^2$ of 0.739, $r^2$ of 0.847 and SEE of 0.344. The generated models were externally validated using test sets. The final QSAR models as well as the information gathered from 3D contour maps should be useful for the design of novel tetraoxanes having improved antimalarial activity.

Keywords

References

  1. Padmanaban, G.; Nagaraj, V. A.; Rangarajan, P. N. Curr. Sci. 2007, 92, 1545.
  2. Enweronu-Laryea, C. C.; Adjei, G. O.; Mensah, B.; Duah, N.; Quashie, N. B. Malar. J. 2013, 11, 17.
  3. Guiguemde, W. A.; Guy, R. K. Cell. Host. Microbe. 2012, 14, 555.
  4. Nzila, A.; Mwai, L. J. Antimicrob. Chemother. 2010, 65, 390. https://doi.org/10.1093/jac/dkp449
  5. Vroman, J. A.; Alvina-Gaston, M.; Avery, M. A. Curr. Pharm. Des. 1999, 5, 101.
  6. Jefford, C. W. Drug. Dis. Today 2007, 12, 487. https://doi.org/10.1016/j.drudis.2007.04.009
  7. Solaja, B. A.; Terzic, N.; Pocsfalvi, G.; Genena, L.; Tinant, B.; Declerca, J. P.; Kule, D. E.; Milhous, W. K. J. Med. Chem. 2002, 45, 3331. https://doi.org/10.1021/jm020891g
  8. Kumar, N.; Singh, R.; Rawat, D. S. Med. Res. Rev. 2012, 32, 581. https://doi.org/10.1002/med.20223
  9. Zhao, X.; Chen, M.; Huang, B.; Ji, H.; Yuan, M. Int. J. Mol. Sci. 2011, 12, 7022. https://doi.org/10.3390/ijms12107022
  10. Cvijetic, I. N.; Zizak, Z. P.; Stanojkovic, T. P.; Juranic, Z. D.; Terzi , N.; Opsenica, I. M.; Opsenica, D. M.; Jurani , I. O.; Drakulic, B. J. Eur. J. Med. Chem. 2010, 45, 4570. https://doi.org/10.1016/j.ejmech.2010.07.019

Cited by

  1. A Quantitative Structure-Activity Relationship Study on the Antimalarial Activities of 4-Aminoquinoline, Febrifugine and Artemisinin Compounds : vol.5, pp.1, 2013, https://doi.org/10.4018/ijqspr.2020010104